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Shared Medical 
Appointments: An 
Innovative Model 
to Reduce Health 
Disparities Among 
Latinxs With Type-2 
Diabetes
Carolina Espinosa Noya1 , Catherine Chesla1, 
Catherine Waters1, and Abbey Alkon1,2
Abstract
In the United States, diabetes is epidemic. A study of Latinxs with diabetes 
evaluated a behavioral shared medical appointment (SMA) intervention. This 
quasi-experimental study included nonrandomized matched control group 
participants receiving usual care. The nonprobability convenience sample 
consisted of 90 participants (SMA = 30; control = 60) receiving primary 
care at an FQHC (Federally Qualified Health Center) clinic. At 6 months, 
the percentage of participants achieving target A1C goals was greater in the 
intervention group (58.6%) than in the control group (31%; χ2 = 4.462, p 
≤ .05). At 3 months, A1C declined by 0.55% (b = −0.55, t = −1.48, p = 
.14); at 6 months, A1C declined by 0.83% (b = −0.83, t = −2.25, p = .03); 
3- and 6-month declines were greater in the SMA group than in the control 
group. Underserved, underinsured Latinxs in the ALDEA program achieved 
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significant A1C reductions; the program succeeded in empowering Latino 
patients and improving glycemic control.
Keywords
shared medical appointments, group medical visits, Latinxs, Hispanic, type 
2 diabetes
The prevalence of diabetes has increased exponentially over the last three 
decades and has reached epidemic proportions in the United States. An 
astounding 29.1 million people—9.3% of the U.S. population—currently 
lives with diabetes (Centers for Disease Control and Prevention, 2017). 
Moreover, abundant research has documented persistent racial–ethnic dis-
parities in both diabetes prevalence rates and quality of care. In comparison 
with White counterparts, fewer Latinxs, African Americans, and Native 
Americans who have type 2 diabetes receive standard diabetes care, such as 
immunizations, foot examinations, ophthalmology screenings, and diabetes 
education (Brown & Hanis, 2014).
Although over the last 10 years the population of people with type 2 diabe-
tes has made steady progress toward achieving goals regarding glycated hemo-
globin (A1C; ≤ 7% or ≤ 8%), blood pressure (BP; ≤ 140/90), and low density 
lipoprotein (LDL; ≤ 100), the percentage of this population that misses target 
goals remains high—between 33% and 49% (Stark Casagrande, Fradkin, 
Saydah, Rust, & Cowie, 2013). Nationwide, only 14% of people with diabetes 
meet all three target goals (A1C, BP, and LDL) and are nonsmokers (Stark 
Casagrande et al., 2013). Despite the known efficacy of Diabetes Self-
Management Education and Support (DSMES; Brown & Hanis, 2014), only 
half of the adults with diabetes report ever receiving formal diabetes education 
or attending self-management classes (Stark Casagrande et al., 2013).
In response to the deficits in standard medical care for adults with diabe-
tes, the American Diabetes Association (ADA; 2019) called for a change in 
the delivery of care to improve diabetes management and outcomes. 
Furthermore, the ADA proposed the chronic care model (CCM) as an effec-
tive framework for improving quality of care for people with diabetes (ADA, 
2019). The CCM includes six core elements: (a) delivery system redesign, (b) 
self-management support, (c) decision support, (d) clinical information sys-
tems, (e) community resources and policies, and (f) health systems. Over the 
last decade, evidence has emerged suggesting CCM is an effective frame-
work to improve the care of individuals with chronic disease (Coleman, 
Austin, Brach, & Wagner, 2009).
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As an intervention for adults with diabetes, shared medical appointments 
(SMAs) include at least three of the CCM’s six core components: delivery 
system redesign, self-management support, and decision support. SMA con-
stitutes a model of care where planned visits are coordinated for a group of 
patients in the context of a multidisciplinary team (Coleman et al., 2009; 
Wagner et al., 2001). This model has become a popular method to increase 
access to DSMES in the context of primary care (Cohen et al., 2011; Edelman 
et al., 2010; Housden, Wong, & Dawes, 2013; Taveira, Dooley, Cohen, 
Khatana, & Wu, 2011; Taveira et al., 2010). SMAs are a promising alterna-
tive to individual office visits because DSMES and peer support are inte-
grated within the primary care visit, collaborative relationships between 
providers and patients can be nurtured, and group activities can be used to 
refine patients’ disease management skills and enhance knowledge (Edelman, 
Gierisch, McDuffie, Oddone, & Williams, 2015).
Research on the effectiveness of SMAs to improve diabetes outcomes for 
Whites has emerged, and there is sufficient evidence on the effectiveness of 
SMAs on A1C and BP to support the implementation of SMAs among White 
adults with type 2 diabetes (Edelman et al., 2015; Housden et al., 2013). The 
impact of SMAs on A1C and BP is not only statistically significant, but also, 
more importantly, clinically significant. Two separate meta-analyses revealed 
that SMAs improved A1C by 0.6 percentage points, findings similar to 
another meta-analysis (Housden et al., 2013). Although a change of 0.6% 
may seem modest, given the United Kingdom Prospective Diabetes Study 
(UKPDS) findings, a decrease of 0.6% A1C translates to a decrease of 
approximately 10.5% deaths related to diabetes, 7% myocardial infarctions, 
and 19% microvascular complications (Stevens, Kothari, Adler, & Stratton, 
2001). Edelman et al. also found a clinically significant decrease of 5 mmHg 
in systolic BP among SMA participants (Edelman et al., 2015; Housden et al., 
2013). To provide context, a classic hypertension study found that after add-
ing a first-line medication for hypertension treatment, the expected improve-
ment after 1 year of treatment was approximately 6.6 mmHg (Piller et al., 
2014). Edelman points out that SMA patients achieved 75% of the level of 
improvement seen with a first-line medication for hypertension (Edelman 
et al., 2015).
Unfortunately, research on SMA effectiveness has, for the most part, 
excluded monolingual Spanish-speaking Latinxs (Gutierrez, Gimple, Dallo, 
Foster, & Ohagi, 2011). The only study to focus on low-income, uninsured 
Latinxs was conducted by Gutierrez and colleagues (2011) in a randomized 
control trial (RCT) of 93 patients. Unfortunately, the authors did not state 
whether the participants were monolingual or bilingual or whether the SMA 
was culturally tailored. Findings revealed a mean A1C decrease of 1.19% in 
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the SMA group (p < .01) versus a decrease of 0.67% in the control group (p 
< .02). The paucity of research on Latinxs subpopulations and the paucity of 
interventions that are culturally tailored for Spanish-speaking Latinxs living 
with type 2 diabetes indicate a need to expand this research and develop the 
interventions.
Purpose
The purpose of this study was to evaluate the effectiveness of a nurse practi-
tioner–led behavioral SMA intervention, referred to as “ALDEA” (Latinxs 
con Diabetes en Acción). In the study, a group of patients who participated in 
an SMA intervention was compared with a similar control group of patients 
who received usual primary care (UPC) for the treatment of type 2 diabetes; 
the study was conducted over a 6-month period at a Federally Qualified 
Community Health Center (FQHC). The cardiovascular risks measured were 
A1C, LDL, and systolic and diastolic BP. The primary outcome was A1C 
reduction. Secondary outcomes were LDL and BP. The study of the ALDEA 
SMA model, as an innovative model of care for predominantly Spanish-
speaking Latinxs has the potential to identify a sustainable and evidence-
based, culturally tailored model of care to reduce health disparities.
Method
Research Design
This study was a quasi-experimental design with a nonrandomized matched 
control group that followed participants prospectively for 6 months. The 
Institutional Review Board at the University of California, San Francisco, 
approved the study, including the protocol and consent forms. Study enroll-
ment began on January 2015 and ended October 2016.
Setting and Sample
The recruitment of participants took place in a single FQHC in the California 
central coast serving people with low income. Inclusion criteria were Spanish-
speaking Latinxs, older than18 years of age with type 2 diabetes, and must 
have attended at least three SMA sessions. Participants were referred by their 
primary care providers, recruited via flyers and phone calls using the diabetes 
registry at the FQHC.
The 30 participants who comprised the SMA intervention group were 
enrolled in two cohorts. The first cohort consisted of 18 participants and was 
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used to determine the effect size for the study. The second cohort consisted of 
12 participants. A total of 55 eligible participants were approached to partici-
pate in the ALDEA SMA program and 40 chose to participate, for a 72% 
participation rate. Seventy percent of participants indicated that lack of child 
care was the primary reason for nonparticipation. Of the 40 people who chose 
to participate, 10 were excluded from the main analysis because they attended 
less than three SMAs, leaving an intervention group of 30.
The control group was a nonrandom, matched sample, which met the 
aforementioned inclusion criteria and received UPC at the FQHC clinic. 
Intervention and control group participants were individually matched by 
age, (within 5-10 years), and A1C levels (within 0.5%-1%). Each SMA par-
ticipant was matched with their controls within the same time frame of the 
intervention so that baseline and follow-up data were consistent over time.
Based on results from the first cohort of this sample, it was hypothesized 
that the intervention groups’ average change in A1C from baseline to 6 
months would be 1.48% (SD = 2.22%) and the control group would have no 
change in A1C. The difference between a mean (SD) of 1.48% (2.22%) 
change and no change can be expressed as an effect size of 0.667. Using the 
nQuery Advisor Power Program, to determine the sample size needed to 
compare, two unequal independent samples change scores to detect the effect 
size of 0.667 using a t test, 80% power, and a two-tailed alpha of .05. The 
results showed that the total sample size should be 84 (e.g., 28 intervention 
and 56 control group participants). Therefore, we enrolled 30 participants in 
the intervention group and 60 participants in the control group to have enough 
power to test our hypotheses.
Intervention: ALDEA SMAs
ALDEA is a culturally tailored SMA program, developed and implemented 
by the first author in the Spanish language at a single FQHC site (Castro, 
Barrera, & Holleran Steiker, 2010). The cultural adaptation consisted of 
ensuring a team of bilingual and bicultural providers. In addition, materials 
were adapted for low health literacy patients and activities were chosen based 
on cultural relevance. Please refer to Table 1 for a description of adaptive 
changes made to the model. The structure of the SMA intervention was based 
on the model refined by the Veterans Affairs Office (Taveira et al., 2011). In 
this model, groups include peer support, DSMES with a focus on behavioral 
approaches (SMART goals and problem solving), and medical management. 
SMART goals are specific, measurable, agreed upon, realistic and time-
based. The ALDEA SMA program team consisted of a lead family nurse 
practitioner (FNP), an FNP student, a medical assistant, and a volunteer 
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registered nurse. Patients continued to access their primary care provider, at 
the same FQHC clinic, for routine care.
The ALDEA SMA program had an open enrollment policy, where partici-
pants could join at any given time, and groups were limited to 12 patients per 
group. The SMA intervention was offered once a week for 2 hr on an ongoing 
basis. During the first year of the SMA group meetings, only a morning group 
was offered. An evening group was added in the second year. In the second 
year, participants had the choice to attend the morning or evening sessions. 
There were a total of approximately 24 SMA sessions during the first 6 
months of the program for each cohort.
Procedures
Intervention group: SMA sessions. The SMA sessions used a group process to 
provide support, education, and patient activation. Motivational interviewing 
(MI; Miller & Rollnick, 2012) and group processes were used to promote col-
laborative goal setting and problem solving in the form of individual action 
plans and were integrated into individual visits/check-ins as well as group 
activities. The individual component included the following: patient 
Table 1. Cultural Adaptation of ALDEA Shared Medical Appointment Model.
Issues to Consider Adaptation
Social 
determinants
Low SES/insurance 
status
Low-cost pharmacy
Low-cost/free diabetes supplies
LHL Screening for LHL included in intake 
form
Food distribution established on-site
Language barriers Bicultural and bilingual team
Cultural 
considerations
Respeto Cultural humility training for 
bicultural and bilingual team
Familismo Family members invited to participate
Consideration of family in planning 
and execution of SMART goals
Time orientation Flexible schedule, late arrival 
normalized
Herbal medicine Use of herbal medicine integrated 
into intake form
Note. SES = socioeconomic status; LHL = low health literacy.
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registration, vital signs, medication reconciliation, and individual assessment 
of diabetes management (laboratory findings, orders, medication refills, medi-
cation titration, review of SMART goals and action plans, and referrals).
The content of the SMA sessions was participant-driven. Participants 
decided every week what content and activities they wished to engage in the 
following week. Activities included, but were not limited to, didactic ses-
sions, hands-on experiential learning, exercise, group discussions, recipe 
sharing and cooking activities. SMA visits included a brief individual medi-
cal evaluation during which the medical provider reviewed and revised 
SMART goals in collaboration with each participant. During this time, the 
provider engaged in problem solving as necessary to explore barriers and 
define new goals. Similarly, during group education, interaction, or activities, 
the group engaged in problem-solving in relation to their treatment barriers 
and the topic being discussed, and supported each other in goal setting. In 
addition, medical care was coordinated with primary care services delivered 
by a different PCP within the FQHC.
The current literature on structural barriers among low-income Latinxs 
has identified the following factors to be considered in the implementation of 
diabetes health interventions; lack of health insurance, low health literacy, 
food insecurity, limited diabetes knowledge, language barriers and low accul-
turation levels (Olson, Sabogal, & Perez, 2008). The cultural adaptation of 
the ALDEA SMA model consisted of a professional team of bilingual and 
bicultural providers. In addition, materials were adapted for low health liter-
acy patients and activities were chosen based on cultural relevance. In an 
attempt to lessen the burden of food insecurity and lack of health insurance 
resources, policies were implemented at the FQHC at large (Table 1).
UPC group. The UPC group participants received the clinic’s standard of care for 
persons with diabetes. Standard of care consisted of quarterly individual clinic 
visits with a primary care provider (i.e., MD, FNP, or PA) of approximately 20 
min. Referrals to DSMES in the community were made routinely as part of 
standard of care. There were no dieticians or diabetes educators available onsite.
Measures
Demographic variables were obtained from the medical records of interven-
tion and control group participants, as were laboratory values of A1C, sys-
tolic and diastolic BP, and LDL. The data were extracted from a clinic-based 
diabetes registry system. This data system was created and verified by two 
data analysts, thus increasing the accuracy and reliability of the data.
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Demographic variables. The following demographic data were collected at 
baseline: chronological age (in years), sex, ethnicity, number of diagnosed 
chronic diseases, poverty level (defined per federal guidelines), and health 
insurance (yes or no for any type of comprehensive insurance, public or pri-
vate payer).
Outcome variables. The study had three outcome variables: hemoglobin A1C, 
LDL, and BP.
Hemoglobin A1C. The primary outcome, A1C, was measured with a high-
performance liquid chromatography method used by the Bio-Rad Hercules 
laboratory. Data were obtained at baseline and at 3 and 6 months. If a par-
ticipant had more than one measurement in a 90-day interval, the average 
of all A1C levels collected during the interval was used. Hemoglobin A1C 
levels obtained within 24 hr of the first SMA appointment were considered 
to be pre-SMA baseline data. Post-SMA data points were calculated as time 
from first SMA appointment. Data from all participants were then aggregated 
based upon corresponding time intervals every 3 months. Quarterly measures 
of A1C are part of the ADA guidelines of care for people with diabetes and 
were routinely collected in this clinic.
LDL. The value of the last LDL, closest to the 6-month post-intervention 
data collection point, was utilized. Per current guidelines, the LDL variable 
was dichotomized (yes/no) as to whether the participant achieved the recom-
mendation of less than 100 mg/dL (Cornell, 2017).
BP. Both systolic (SBP) and diastolic blood pressure (DBP) were mea-
sured using calibrated manual cuffs, taken by a medical assistant or nurse 
practitioner student at each clinic or SMA visit. The BP values closest to the 
6-month time, post-baseline data collection, was used for analysis. Per cur-
rent guidelines, the BP variable was dichotomized (yes/no) as whether the 
participant achieved the recommendation of less than 140/90 (Cornell, 2017).
Data Analysis
Data entry and statistical analyses were conducted using SPSS 19. Descriptive 
statistics were used to summarize the data and identify outliers. Differences 
in the demographics and study variables between the intervention group and 
the control group were calculated using Student’s t test for independent 
groups, chi-square or Fisher exact tests. A1C was compared by group, at 
baseline, 3 months, and 6 months. Differences in the percentage of 
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participants in each group who achieved A1C, LDL, BP, and all three target 
goals, per the ADA guidelines (A1C <7% or <8% for patients with multiple 
comorbidities or increased risk hypoglycemia, LDL < 100 mg/dl, BP < 
140/90 mmHg), were compared at 6 months (ADA, 2019). These variables 
were dichotomized and coded as on target (1) and not on target (0). Chi-
square analyses were used to evaluate the difference in the percent of partici-
pants reaching target goals for each outcome variable (A1C, LDL and BP). 
Finally, to evaluate the impact of the subjects who left the study, differences 
in baseline demographics and A1C were compared between participants with 
complete versus missing data.
To test the effect of group membership on A1C change, differences in 
change scores were compared between the ALDEA SMA intervention group 
and the UPC. Change scores were operationalized as the reduction in A1C at 
3 months (3 months minus baseline) and reduction at 6 months (6 months 
minus baseline). Two sets of analyses were carried out. First, as intent to treat 
analysis, which included all 40 SMA participants regardless of number of 
sessions attended. The second analysis included the 30 participants who met 
the attendance inclusion criteria of three SMA sessions. For both, linear 
regression analysis was computed to assess if mean A1C change from base-
line to 3 and 6 months was greater among SMA intervention group partici-
pants compared with the UPC control group participants, with baseline A1C 
as a covariate in the model.
Results
There were a total of 24 SMA sessions during the first 6 months of the program 
for both intervention cohorts. Each session included a mean of seven partici-
pants, who attended a mean of 13 and a median of seven SMA sessions.
The mean age of the sample was 53 years ± 12.3 years. The majority of 
the participants were at or below the Federal Poverty Line. In the sample, 
61% had health insurance and participants had an average of 2.4 ± 1.4 
chronic conditions per medical records. There were no significant differences 
at baseline between ALDEA SMA intervention cohorts 1 and 2 in terms of 
age (p = .35), poverty level (p = .54), number of chronic conditions (p = 
.43), or insurance status (p = .33). Consequently, intervention cohorts 1 and 
2 were combined for the remaining of the analyses. There were no statisti-
cally significant differences on demographic variables or baseline A1C 
between those with complete or missing data.
At baseline, there were no statistically significant differences in age (p = 
.32), sex (p = .39), poverty (p = .18), health insurance status (p = .35), and 
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comorbidities (p = .69) between the ALDEA SMA intervention group and 
the matched UPC control group (Table 2).
A1C. There were no statistically significant differences in mean A1C values 
at baseline, 3 month or 6 months between ALDEA SMA and UPC partici-
pants (Table 3). There was a statistically significant difference in the percent-
age of participants who achieved the target A1C goal at 6 months 
post-intervention for the SMA participants (58.6%) versus the control group 
participants, 31%; χ2(1) = 4.462, p = .03; Figure 1.
There was a statistically significant change in A1C for the intervention 
versus control participants at 6 months, F(2, 50) = 28.16, p = .00, but not at 
3 months post-SMA intervention, F(2, 55) = 31.92, p = .00; Table 4. There 
Table 2. Demographic Characteristics of Study Participants.
Demographic Characteristic
ALDEA SMA  
(n = 30)
Control  
(n = 60)
pM SD M SD
Age (years) 54.87 12.7 51.85 12.1 .32
Poverty level 83.70 53.9 109.00 124.7 .18
Number of chronic conditions 2.41 1.8 2.31 1.1 .69
SMA = shared medical appointment.
Figure 1. Percent of participants on Target A1C at baseline and 6 months.
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was a reduction of A1C by 0.55% (b = −0.55, t = −1.48, p = .14) from base-
line to 3 months and a reduction of 0.83% (b = −0.83, t = −2.25, p = .03) 
from baseline to 6 months, in favor of the SMA participants. Intent-to-treat 
analysis revealed that the reductions of A1C were greater in the intervention 
group at 6 months (b = −0.81, t = −2.46, p = .02), but not at 3 months (b = 
−0.52, t = −1.63, p = .11).
The majority of the participants in the intervention group (90%) and in the 
control group (89%) had on-target BP values at 6 months, χ2(df) = 0.045(1), 
p = .832. Sixty-five percent of SMA participants compared with 50% of 
control group participants had on-target LDL values at 6 months, χ2(df) = 
1.66(1), p = .11. Finally, although not statistically significant, it is of clinical 
significance to note that 32% of intervention group participants compared 
with 15% of control group participants achieved the on-target goals for all 
three criteria, A1C, LDL, and BP; χ2(df) = 2.83(1), p = .24.
Discussion
To our knowledge, this study with a matched control group is among the first 
to document the impact of a culturally adapted SMA model to improve 
Table 3. Clinical Characteristics of Study Participants.
Clinical 
Parameters
ALDEA SMA  
(n = 30)
Control  
(n = 60)
pM SD M SD
A1C, baseline 9.97 2.43 9.44 2.06 .25
A1C, Month 3 8.52 1.69 8.71 1.70 .48
A1C, Month 6 8.01 1.46 8.72 1.71 .10
Note. SMA = shared medical appointment.
Table 4. Changes in A1C at 3 Months and 6 Months: SMA Participants Versus 
Control Participants (Controlling for Baseline A1C).
SMA Predicting 
A1C Changea n
Unstandardized 
β SE β t Statistic p Model Statistics
At 3 months 57 −0.55 −0.37 −1.48 .14 F(2, 55) = 31.92, 
p = .00
At 6 months 52 −0.83 0.37 −2.25 .03a F(2, 50) = 28.16, 
p = .00a
Note. Intervention (SMA = 1, Control = 0). A1C = Hemoglobin A1C; SMA = shared 
medical appointment.
a. Change is defined as A1C at 3 months or at 6 months minus baseline A1C.
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glycemic control among low-income, Spanish-speaking Latinxs living with 
type 2 diabetes. This study demonstrated that underserved Latinxs enrolled in 
the ALDEA program, a culturally sensitive, community-based, nurse practi-
tioner–led, SMA model, was able to achieve A1C goals in greater numbers com-
pared with those who received UPC. Furthermore, the ALDEA SMA intervention 
led to a net reduction of −0.55% at 3 months, and a statistically significant net 
reduction of −0.83% at 6 months in A1C compared with UPC participants. These 
differences are also clinically significant and mirror the outcomes in other studies 
of SMA effectiveness in reducing A1C. Edelman and colleagues reported in their 
meta-analysis a net reduction of 0.6% in A1C in favor of SMA Edelman et al., 
2015. The clinical significance is contextualized by the the UKPDS, which found 
that a 1% decrease in A1C values translated to a 14% decrease in macrovascular 
diseases, a 37% decrease in microvascular complications and a 21% decrease 
risk of deaths related to diabetes (Stevens et al., 2001).
The prevalence of adults with type 2 diabetes that meet the A1C, BP, and 
LDL recommendations in the United States vary by ethnicity (Stark 
Casagrande et al., 2013). Stark and colleagues analyzed NHANES (National 
Health and Nutrition Examination Survey) data and noted that Mexican 
Americans were less likely than their White counterparts to meet A1C and 
LDL goals, 46% versus 52% and 45% versus 62% respectively (Stark 
Casagrande et al., 2013). The ALDEA SMA participants demonstrated a 
higher percentage of achieving recommended goals compared with the UPC 
participants for A1C (58.6% vs. 31%), BP (90% vs. 85%), and LDL (65.4% 
vs. 50%) and 32% of the ALDEA SMA group versus 15% of the UPC group 
met all three criteria. Thus, ALDEA SMA participants achieved overall goals 
well above national trends both for Latinxs and for the NHANES sample, 
suggesting the importance and relevance of culturally tailoring an interven-
tion, such as ALDEA SMA, that is culturally specific.
Although these are novel findings, there were limitations to the study. The 
lack of a randomized control group can lead to selection bias. Self-selection 
in the ALDEA SMA program may have favorably influenced the results. 
Patients who chose to participate in the SMA group may have already been 
motivated to improve their health. In addition, while the authors attempted to 
equalize characteristics of participants in the SMA and control groups in this 
quasi-experimental design, the groups may still differ in ways not accounted 
by the matching procedure. Unfortunately, there were restrictions to the study 
design and randomization was not an option in this community setting as the 
SMA ALDEA program had been initiated prior to the study. Non-withstanding, 
and considering the study was underpowered, evidence of this model pro-
vides the foundation for designing a more rigorous, prospective randomized 
trial in the future.
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Another possible threat to internal validity was that of possible design 
contamination. The treatment and control groups were from the same clinic 
and the medical providers may have influenced each other in some way. For 
example, implementation of the ALDEA SMA program might have influ-
enced primary care providers and influenced them to inadvertently change 
the medical care of control participants. This bias could have underestimated 
the outcomes found in the study.
This intervention was implemented at a single site with a relatively homo-
geneous population of low-income, Spanish-speaking Latinxs from Central 
America and Mexico. Although this affects the generalizability of the find-
ings, the importance of including this population in research cannot be under-
stated given the higher prevalence of diabetes and the disparity in diabetes 
outcomes experienced by this population. Future studies should assess the 
feasibility and efficacy of the ALDEA SMA intervention in different settings, 
with different populations, with varied degrees of acculturation, and employ-
ing a different team composition.
Future research on the effectiveness of SMA as a model of care for Latinxs 
should attempt to close some of the gaps in the literature. In particular, com-
parative effectiveness studies are necessary to identify which components of 
the SMA might be responsible for the change and the optimal intervention 
dose. Researchers should attempt to use standardized instruments across 
studies that will allow for meta-analysis, and include not only biophysical 
measures, but also patient-centered outcomes such as self-efficacy, quality of 
life, and patient activation/engagement.
It is important to note that unlike other SMA teams described in the litera-
ture, which often included multiple licensed professionals (i.e., pharmacist, 
medical doctors, psychologists), this team was small and included a nurse 
practitioner, nurse practitioner students, a volunteer nurse, and a medical 
assistant. This team approach may be a cost-effective way to reach the most 
vulnerable and low resourced populations.
In conclusion, given the disproportionate rates of type 2 diabetes and poor 
outcomes among low socioeconomic status Latinxs in the United States, it is 
important that research studies include this vulnerable population. To date, 
there has been only one RCT evaluating the effectiveness of SMA with 
Latinxs (Gutierrez et al., 2011). This study is the first, to our knowledge, to 
document the effect of a culturally tailored SMA program with low income, 
underserved Spanish-speaking Latinxs lead by a nurse practitioner that 
showed a significant decrease in A1C at 6 months post-intervention.
Despite its limitations, the ALDEA SMA program has been successful in 
engaging Latino patients and improving glycemic control; its innovation 
could be disseminated and tested in other settings, populations, and health 
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conditions. The ALDEA SMA model has the potential to reach underserved 
communities and result in significant improvements in the health status 
among the most vulnerable populations.
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